New Monoclonal Antibody for FGFR1 Positive Tumors, Dr. Ilya Tsimafeyeu
Published June 2, 2026
Views 2.36K | Likes 21 | Comments 4
At a glance
Views
2,360
Likes
21
Comments
4
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
New Monoclonal Antibody for FGFR1 Positive Tumors, Dr. Ilya Tsimafeyeu In this ASCO 2026 presentation, Dr. Ilya Tsimafeyeu from the Bureau for Cancer Research discusses the design and early development of the tumor-agnostic TugNod clinical trial evaluating OMRCA01, a novel monoclonal antibody targeting FGFR1-positive …
- Published
- June 2, 2026
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.